Vanguard Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.4M | Buy |
|
|||||
|
2023
Q2 | $507K | Sell |
|
|||||
|
2023
Q1 | $573K | Hold |
|
|||||
|
2022
Q4 | $5.1M | Sell |
|
|||||
|
2022
Q3 | $6.74M | Buy |
|
|||||
|
2022
Q2 | $2.87M | Sell |
|
|||||
|
2022
Q1 | $5.24M | Buy |
|
|||||
|
2021
Q4 | $8.57M | Sell |
|
|||||
|
2021
Q3 | $10.5M | Buy |
|
|||||
|
2021
Q2 | $20.3M | Buy |
|
|||||
|
2021
Q1 | $14.5M | Buy |
|
|||||
|
2020
Q4 | $14M | Buy |
|
|||||
|
2020
Q3 | $4.67M | Buy |
|
|||||
|
2020
Q2 | $4.28M | Buy |
|
|||||
|
2020
Q1 | $1.6M | Buy |
|
|||||
|
2019
Q4 | $1.73M | Sell |
|
|||||
|
2019
Q3 | $2.61M | Sell |
|
|||||
|
2019
Q2 | $3.91M | Buy |
|
|||||
|
2019
Q1 | $3.45M | Buy |
|
|||||
|
2018
Q4 | $4.08M | Buy |
|
|||||
|
2018
Q3 | $2.92M | Buy |
|
|||||
|
2018
Q2 | $790K | Buy |
|